Heart and Cancer commitment, SMP Healthcare Ltd explain in more detail about the AXA PPP approach

When people invest in Private Medical Insurance, the benefits available within a policy for Heart and Cancer claims are often the top priority. The peace of mind that you gain from knowing you have good levels of cover for Cancer or Heart conditions can make all the difference. AXA PPP have a “Heart and Cancer Commitment” in place and they are committed to providing their members who have the enhanced level of cover, access to the market leading cover and care for Heart disease and Cancer conditions. *Members covered by AXA PPP have access to dedicated Cancer and Heart nurses 24 hours a day, 365 days a year. Lianne Harrington, Senior Healthcare Consultant at SMP Healthcare Ltd believes the access to dedicated professionals for even the smallest question is a really important factor. “When we speak to clients who have been diagnosed with Cancer or Heart Disease for the first time, they are often in a complete state of shock. There is so much information provided to them regarding the treatment path that they will take which is sometimes too much to take in. Having access to a dedicated, specialist nurse 24 hours a day/ 365 days a year is[…]






Source:

Dr. Sudhakar Akul Yakkanti Resigns Position as Editor-in-Chief and as member of other Editorial Boards at OMICS Group Journals and Conferences

San Francisco California, May 4, 2016: Effective immediately, Sudhakar Akul Yakkanti, MSc, MPhill & PhD, resigned his position as Editor-in-Chief of Journal of Cancer Science and Therapy (JCST) and as member of other positions held at OMICS Group journals and conferences to pursue a new direction closer to his heart. During his tenure with OMICS Group, Dr. Yakkanti has contributed to the group’s extremely successful efforts in obtaining world-class editorials and the development of successful Cancer Conferences for four consecutive years. Dr. Yakkanti is appreciative of the time he spent with OMICS Group journals and wishes the editorial board colleagues in the respective fields he was associated with only the best. Dr. Yakkanti is a renowned Cell Signaling scientist specializing in tumor angiogenesis and one of the world’s leading authorities on the subject of Type IV collagen derived metabolites. His co-discovery with Dr. Yohei Maeshima of the ‘alpha3 type IV collagen NC1 domain (Tumstatin) sometimes referred to as the ‘alport gene’ also an anticancer gene -made CNN headlines. The article: Tumstatin, an endothelial cell-specific inhibitor of protein synthesis, published in Science [295(5552), 140-143, 2002] changed the view on how endogenous angiogenesis inhibitors inhibit tumor angiogenesis. Dr. Yakkanti is a former Associate Director and Senior Scientist, Center[…]






Source:

Flat 12 Gallery Says The 2014 Nissan GTR is returning badder than ever with a full rebuild

  The #Pennzilla 2014 Nissan GTR is having a full rebuild to turn it into the baddest, meanest, machine for the 2016 Rally season. The 2016 Rally season of fast cars, skillful drivers, and the meanest machines on the planet is just around the corner, but one machine that aims to be the best of the best is #Pennzilla the 2014 Nissan GTR, which is receiving a full rebuild by Flat 12 Gallery. Flat 12 Gallery (www.flat12gallery.com), a boutique licensed Texas dealer that specializes in custom builds and making fast cars slicker and faster aims to turn the car into the envy of every race driver. The #Pennzilla the 2014 Nissan GTR will have more horsepower, a wider body, new wheels, more aggressive front end, sleek spoiler and new graphic design. Race car fans will be able to watch the work being done by following Flat 12 Gallery on Facebook, Instagram, and Twitter! The custom car experts as seen on The Car Chasers and Skidmarks aims to beat their previous record in 2015 when they campaigned #Pennzilla a 2014 GTR on the Coast to Coast GoldRush Rally, The Silver State Classic Challenge winning second in the 1/2 mile shoot out.[…]






Source:

Market Report: Times ‘a Changin’: Oil Flows while Technology Slows April Recap from Thrivent Mutual Funds

  MINNEAPOLIS The slow one now will later be fast….and the first one now will later be last. Bob Dylan’s famous refrain is an apt description of the April stock market, which was led by the four weakest sectors of the past year – Energy, Financials, Materials, and Health Care. On the flip side, Utilities, which had been the best performing sector through the first quarter of 2016, was one of the three worst-performing sectors in April, along with Telecommunications and Information Technology. Also trailing the market were some of the leading technology stocks, which had paced the market last year. Among the worst tech performers this year are Netflix, LinkedIn, Microsoft, and Apple. Overall, most of the movement in the S&P 500 index was sideways throughout April, with the market managing to eke out a slight 0.3 percent gain for the month – and 1 percent for the year. A weak 1st Quarter Gross Domestic Product (GDP) report issued by the U.S. Commerce Department on April 28 precipitated a slight drop in stocks during the final day of the month. The GDP report, which is the broadest measure of economic output, revealed that GDP had grown at a seasonally[…]






Source: